Charles River Laboratories Q3 revenue beats estimates

Charles River Laboratories International

05/11/2025 12:09

Overview

Charles River Q3 revenue falls 0.5% yr/yr to $1 bln, but beats analyst expectations

Adjusted EPS for Q3 beats consensus, reflecting strong operational performance

Company updates 2025 guidance, narrowing full-year outlook for revenue and EPS

Outlook

Charles River narrows 2025 revenue outlook to (1.5)% – (0.5)%

Charles River expects 2025 GAAP EPS of $4.15 – $4.35

Charles River projects 2025 non-GAAP EPS of $10.10 – $10.30

Result Drivers

RESTRUCTURING INITIATIVES - GAAP operating margin improved due to cost savings from restructuring initiatives

REVENUE DECLINE - Lower revenue in Discovery and Safety Assessment and Manufacturing Solutions segments offset by growth in Research Models and Services

VENTURE CAPITAL LOSSES - Decrease in GAAP net income and EPS driven by losses from venture capital and strategic investments

Key Details

Metric
Beat/Miss
Actual
Consensus Estimate
Q3 Revenue
Beat
$1 bln
$990.76 mln (11 Analysts)
Q3 Adjusted EPS
Beat
$2.43
$2.33 (13 Analysts)
Q3 EPS
$1.10
Q3 ADJUSTED NET INCOME
Beat
$120.30 mln
$117.23 mln (8 Analysts)
Q3 NET INCOME
$54.42 mln


Analyst Coverage

The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 8 "strong buy" or "buy", 11 "hold" and no "sell" or "strong sell"

The average consensus recommendation for the biotechnology & medical research peer group is "buy"

Wall Street's median 12-month price target for Charles River Laboratories International Inc is $195.00, about 8.8% above its November 4 closing price of $177.85

The stock recently traded at 17 times the next 12-month earnings vs. a P/E of 17 three months ago

Press Release: ID:nBw9lq5l9a

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)